Publications pursuant to § 40 sec. 1 WpHG
Pursuant to §§ 33 et seq. of the German Securities Trading Act (Wertpapierhandelsgesetz - WpHG), any person whose shareholding in an issuer reaches, exceeds or falls below 3%, 5%, 10%, 15%, 20%, 25%, 30%, 50% or 75% of the voting rights by purchase, sale or by any other means shall, without undue delay, at the latest within four trading days, notify this to the Issuer and simultaneously to the Supervisory Authority (BAFIN).
The nominal capital of Fresenius Medical Care AG & Co. KGaA relevant for the calculation of the thresholds currently amounts to €304,444,441.00 and is divided into 304,444,441 no-par-value shares.
Please use the following e-mail address for any notifications or send us a fax at +49 6172 608-3993967:
Pursuant to § 40 section 1 WpHG, the Issuer is then required to publish such notification without undue delay within certain stipulated deadlines on a Europe-wide basis. This is published via DGAP (Deutsche Gesellschaft für Ad-hoc-Publizität mbH).
The latest notifications of investors having reported crossing of thresholds pursuant to § 33 WpHG are listed below: